Bioservo Technologies AB logo

BIOS - Bioservo Technologies AB Share Price

SEK14.55 0.4  2.8%

Last Trade - 5:00pm

Sector
Healthcare
Size
Micro Cap
Market Cap £19.1m
Enterprise Value £14.6m
Revenue £998k
Position in Universe 1392nd / 1857
Bullish
Bearish
Unlock BIOS Revenue
Momentum
Relative Strength (%)
1m -9.78%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -24.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
3.60 3.76 4.67 6.71 9.27 11.7 96.0 178 +26.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BioservoTechnologies AB revenues increased 26% to SEK11.7M. Netloss increased 13% to SEK26.3M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Higher net lossreflects Personal Expenses increase of 2% to SEK22.9M(expense), Depreciation & Amortization increase of 5% toSEK4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIOS Revenue Unlock BIOS Revenue

Net Income

BIOS Net Income Unlock BIOS Revenue

Normalised EPS

BIOS Normalised EPS Unlock BIOS Revenue

PE Ratio Range

BIOS PE Ratio Range Unlock BIOS Revenue

Dividend Yield Range

BIOS Dividend Yield Range Unlock BIOS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIOS EPS Forecasts Unlock BIOS Revenue
Profile Summary

Bioservo Technologies AB is a Sweden-based company within wearable technologies based on bionic soft robotics. It is engaged in developing, producing and selling muscle strengthening equipment based on the patented SEM Technology (Soft Extra Muscle Technology). The technology implies so called intention detection logic that activates the support if the wearer initiates movement with a natural and intuitive movement. This is achieved by sensors that detect the user’s action and strengthens this action by activating the motors. Its main product is a SEM Glove. The products are designed for people that have an impaired grip strength caused by injured nerves, weakening in the muscles or pain in the muscles/muscular attachments. The product is applicable in the healthcare and industry sectors.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since May 22, 2017
No. of Shareholders: n/a
No. of Employees: 28
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 15,798,321
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIOS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIOS
Upcoming Events for BIOS
Frequently Asked Questions for Bioservo Technologies AB
What is the Bioservo Technologies AB share price?

As of 5:00pm, shares in Bioservo Technologies AB are trading at SEK14.55, giving the company a market capitalisation of £19.1m. This share price information is delayed by 15 minutes.

How has the Bioservo Technologies AB share price performed this year?

Shares in Bioservo Technologies AB are currently trading at SEK14.55 and the price has moved by 5.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioservo Technologies AB price has moved by -1.05% over the past year.

What are the analyst and broker recommendations for Bioservo Technologies AB?

There are no analysts currently covering Bioservo Technologies AB.

When will Bioservo Technologies AB next release its financial results?

Bioservo Technologies AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Bioservo Technologies AB dividend yield?

Bioservo Technologies AB does not currently pay a dividend.

Does Bioservo Technologies AB pay a dividend?

Bioservo Technologies AB does not currently pay a dividend.

When does Bioservo Technologies AB next pay dividends?

Bioservo Technologies AB does not currently pay a dividend.

How do I buy Bioservo Technologies AB shares?

To buy shares in Bioservo Technologies AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioservo Technologies AB?

Shares in Bioservo Technologies AB are currently trading at SEK14.55, giving the company a market capitalisation of £19.1m.

Where are Bioservo Technologies AB shares listed? Where are Bioservo Technologies AB shares listed?

Here are the trading details for Bioservo Technologies AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: BIOS
What kind of share is Bioservo Technologies AB?

Based on an overall assessment of its quality, value and momentum, Bioservo Technologies AB is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bioservo Technologies AB share price forecast 2021?

Shares in Bioservo Technologies AB are currently priced at SEK14.55. At that level they are trading at 72.01% discount to the analyst consensus target price of 0.00.

Analysts covering Bioservo Technologies AB currently have a consensus Earnings Per Share (EPS) forecast of 0.2 for the next financial year.

How can I tell whether the Bioservo Technologies AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioservo Technologies AB. Over the past six months, the relative strength of its shares against the market has been 2.52%. At the current price of SEK14.55, shares in Bioservo Technologies AB are trading at 10.52% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioservo Technologies AB PE Ratio?

We were not able to find PE ratio data for Bioservo Technologies AB.

Who are the key directors of Bioservo Technologies AB?

Bioservo Technologies AB's management team is headed by:

Johan Ingvast - OTH
Hans von Holst - IND
Mattias Jamtin - DSL
Laurent Krummenacher - OTH
Martin Wahlstedt - OTH
Anett Grusser-Pettersson - OTH
Peter Lowendahl - OTH
Anders Lundmark - CHM
Runar Bjorklund - DRC
Carin Ruiz - DRC
Kunal Pandit - DRC
Petter Backgren - CEO
Nikolaj Soerensen - DRC
Jacob Michlewicz - CFO
Mikael Wester - DMK
Who are the major shareholders of Bioservo Technologies AB?

Here are the top five shareholders of Bioservo Technologies AB based on the size of their shareholding:

Similar to BIOS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.